iShares Neuroscience and Healthcare ETF Rating $25.67 +0.53 (+2.11%) As of 01/21/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings iShares Neuroscience and Healthcare ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBRN Aggregate RatingModerate Buy 2.82Holdings in IBRN have an aggregate rating of Moderate Buy based on 384 analyst ratings issued in the past year covering 41 companies (85.6% of the portfolio).IBRN Aggregate Price Target$25.67High Prediction$25.67Average Prediction$25.67Low Prediction$25.67Holdings in IBRN have an aggregate price target of $25.67 and a range of $25.67 to $25.67 covering 41 companies (85.6% of the portfolio).IBRN Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy24 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Neuroscience and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 41 IBRN Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.47%NBIXNeurocrine Biosciences$145.88+1.8%4.8812 of 5 stars2.83$164.81 13.0%23News Coverage4.16%ARGXargenx$647.39+1.1%2.3342 of 5 stars2.86$658.39 1.7%22Gap Up4.15%SUPNSupernus Pharmaceuticals$38.58+2.2%3.7402 of 5 stars2.67$46.50 20.5%3Positive News4.13%ITCIIntra-Cellular Therapies$126.50+0.2%3.8263 of 5 stars2.67$100.31 -20.7%154.11%SRRKScholar Rock$44.88+4.1%2.9294 of 5 stars3.14$40.43 -9.9%7Insider TradeNews Coverage4.04%ACADACADIA Pharmaceuticals$17.89+1.8%3.9071 of 5 stars2.59$25.25 41.1%174.00%CPRXCatalyst Pharmaceuticals$22.92+0.6%4.7936 of 5 stars3.00$32.86 43.4%7News Coverage3.98%BIIBBiogen$140.98+0.3%4.7341 of 5 stars2.43$230.00 63.1%283.98%PTCTPTC Therapeutics$45.25+3.2%4.003 of 5 stars2.47$55.00 21.5%153.95%SRPTSarepta Therapeutics$116.79-1.0%4.9629 of 5 stars2.91$178.71 53.0%223.82%ALKSAlkermes$30.10+2.1%4.5391 of 5 stars2.64$36.00 19.6%113.77%XENEXenon Pharmaceuticals$38.98+1.2%2.7892 of 5 stars3.13$56.00 43.7%8Positive News3.47%EWTXEdgewise Therapeutics$27.39+4.3%2.1524 of 5 stars3.00$43.17 57.6%6Short Interest ↑3.40%IARTIntegra LifeSciences$25.12+4.2%3.5869 of 5 stars1.75$23.00 -8.4%83.35%DYNDyne Therapeutics$14.55+3.0%3.5886 of 5 stars3.08$49.91 243.0%13News Coverage3.34%BHVNBiohaven$39.09+4.0%2.7267 of 5 stars3.07$63.00 61.2%14Gap Up3.00%PRAXPraxis Precision Medicines$78.26+10.9%2.2525 of 5 stars2.89$149.11 90.5%9Analyst ForecastNews CoverageGap Up2.12%AVDLAvadel Pharmaceuticals$7.90+1.9%3.4143 of 5 stars3.00$21.00 165.8%7Gap Up2.07%AVXLAnavex Life Sciences$9.85+6.9%3.7051 of 5 stars3.33$44.00 346.7%3Analyst Forecast1.56%AXGNAxoGen$18.97+4.9%1.4944 of 5 stars3.00$16.00 -15.7%3Positive News1.52%PRTAProthena$14.11+2.5%2.3931 of 5 stars2.71$46.50 229.6%7Positive News1.26%CAPRCapricor Therapeutics$14.06+2.6%1.9487 of 5 stars3.00$34.50 145.4%6Positive NewsGap Up1.07%SGMOSangamo Therapeutics$1.13+3.7%2.8259 of 5 stars2.67$5.50 386.7%6Gap Down1.05%ANNXAnnexon$4.17-0.7%2.4444 of 5 stars3.00$15.80 278.9%61.00%ZVRAZevra Therapeutics$8.15+1.2%2.0434 of 5 stars3.13$21.57 164.7%80.94%DNTHDianthus Therapeutics$21.66+8.3%1.8697 of 5 stars3.20$46.43 114.4%10Short Interest ↑0.86%TRDAEntrada Therapeutics$13.06+2.9%2.7363 of 5 stars3.25$25.67 96.5%4Positive News0.85%CLPTClearPoint Neuro$18.42+22.5%1.1571 of 5 stars3.00$16.33 -11.3%3Analyst ForecastNews CoverageGap UpHigh Trading Volume0.82%NGNENeurogene$16.62+0.1%2.7244 of 5 stars3.13$60.83 266.0%8Gap Down0.74%RAPPRapport Therapeutics$13.27+4.6%1.7673 of 5 stars3.00$35.00 163.8%3Gap Down0.61%TSHATaysha Gene Therapies$1.533.5171 of 5 stars3.00$6.63 333.0%80.60%VNDAVanda Pharmaceuticals$4.51+3.4%4.0782 of 5 stars3.00$15.50 243.7%2Analyst Forecast0.58%VYGRVoyager Therapeutics$5.22+3.0%4.8944 of 5 stars3.11$15.97 205.9%9Gap Down0.50%ABEOAbeona Therapeutics$5.19-0.6%3.7084 of 5 stars3.00$18.00 246.8%3News Coverage0.46%CTNMContineum Therapeutics$11.28-9.3%1.3851 of 5 stars3.20$29.25 159.3%5News Coverage0.38%AMLXAmylyx Pharmaceuticals$3.45-4.2%3.1388 of 5 stars2.56$7.33 112.6%9Gap DownHigh Trading Volume0.33%LRMRLarimar Therapeutics$3.43+2.7%1.2274 of 5 stars3.09$20.43 495.6%110.30%SLDBSolid Biosciences$3.26-0.3%3.7316 of 5 stars3.31$15.30 369.3%13News CoverageGap Up0.30%ALECAlector$1.73+1.2%4.4284 of 5 stars2.14$3.75 116.8%7Gap Up0.30%NVRONevro$4.68+2.3%2.8552 of 5 stars1.77$6.30 34.8%13Gap Up0.23%SAVACassava Sciences$2.62-4.7%4.4444 of 5 stars2.50$111.50 4,155.7%2 This page (NYSEARCA:IBRN) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Neuroscience and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Neuroscience and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
